Actively Recruiting

Age: 18Years +
All Genders
ID03260842

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Led by Stanford University · Updated on 2025-04-01

500

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying two groups of patients who are at high risk for developing pancreatic cancer. One group includes patients diagnosed with pancreatic cysts who are undergoing endoscopic ultrasound or surgery. The other group includes patients considered high risk due to family history or known genetic mutations. The purpose is to collect and analyze bio-specimens to better understand early detection of pancreatic cancer. The study collects bio-specimens such as pancreatic cyst fluid and blood from patients with pancreatic cysts during their clinical procedures. For high-risk individuals without cysts, blood samples are collected. All collections follow a standard operating protocol. This is an observational study, so no treatments are given; the focus is on gathering samples and monitoring over time. Participants will provide bio-specimens as part of their routine care or scheduled visits. Researchers will evaluate these samples and observe participants over 5 to 10 years to track the development of pancreatic cancer. The study involves ongoing data collection and long-term monitoring to help identify early signs of the disease. The total participation duration varies depending on individual follow-up.

CONDITIONS

Brief Title

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Older than 18 with pancreas cyst
  • Older than 18 at high risk for Pancreas cancer
Not Eligible

You will not qualify if you...

  • Unable to provide consent
  • Not willing to provide bio-specimens

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 1 day

Participants undergo collection of bio-specimens including pancreatic cyst fluid and blood or blood only, depending on their cohort.

1 to 2 visits depending on cohort and procedure

Long-term Monitoring

Duration - 5 to 10 years

Participants are observed over time to monitor for development of pancreas cancer.

Periodic visits for bio-specimen collection and observation

Trial Site Locations

Total: 1 location

1

Stanford University

Stanford, California, United States, 94035

Actively Recruiting

Loading map...

Research Team

W

Walter Park, MD

S

Sharon Pneh

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Combination of Rectal Indomethacin and Cold Water Irrigation...

Pancreas Disease

Actively Recruiting

1 location

Development of Biomarkers for the Early Detection, Surveilla...

Pancreatic Cancer

Actively Recruiting

13 locations

Artificial Intelligence in Endoscopic Ultrasound to Detect P...

Pancreatic Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here